Oncoradiomics SA
20.2 FTEOncoradiomics reported total assets of €4.31m at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Jul 2026), with 20.2 full-time equivalents.
The score of Oncoradiomics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +18 % Headcount (avg FTE) -28 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Oncoradiomics's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jul 2026
- Year ended 31 Dec 2024filed on 02 Feb 2026
- Year ended 31 Dec 2023filed on 05 Aug 2024
- Year ended 31 Dec 2022filed on 10 Jul 2023
- Year ended 31 Dec 2021filed on 06 Sep 2022
Oncoradiomics's financial analysis
- Solvency-0.1%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Oncoradiomics
Oncoradiomics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0662.719.440
- VAT number
- BE0662719440
- Peppol
- Registered · 0208:0662719440 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 19 Sep 2016
- Registered office
- 4000 Liège
- Size
- Small · 20.2 FTE
- Latest accounts
- 2025 · filed on 03 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Oncoradiomics (SA) has been based in Liège since 2016, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 284,677 € and equity of −3,807 €; its revenue is not published. With 20.2 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at -0.1%, below the median of its sector (58.2%).
Companies similar to Oncoradiomics
Companies in the same business, of comparable size and area, outside its group.
- Axis44 Research and experimental development on natural sciences and engineering Jodoigne · balance sheet €2.45m
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- DR. Johan Vanden Broucke Research and experimental development on natural sciences and engineering Ypres · balance sheet €1.88m
- ProtonW.be Research and experimental development on natural sciences and engineering Charleroi · balance sheet €1.27m
- Nyemb Research and experimental development on natural sciences and engineering Tournai · balance sheet €1.15m
- Drs Pipeleers & Marichal Research and experimental development on natural sciences and engineering Roosdaal · balance sheet €2.05m
- Dokter Fries Claerhout Research and experimental development on natural sciences and engineering Poperinge · balance sheet 906,181 €
- IR 4 Research and experimental development on natural sciences and engineering Auderghem · balance sheet 865,084 €
Frequently asked questions about Oncoradiomics
What is the revenue of Oncoradiomics?
Oncoradiomics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Oncoradiomics?
In Belgium, the VAT number is the company number prefixed with BE: BE0662719440 for Oncoradiomics, if the company is VAT-registered. Its company number (CBE) is 0662.719.440.
Where is the registered office of Oncoradiomics?
According to the CBE register, the registered office of Oncoradiomics is in 4000 Liège.
What is the equity of Oncoradiomics?
At the close of the 2025 financial year, the equity of Oncoradiomics amounts to -3,807 €, a solvency of -0.1% of total assets.
How many people work at Oncoradiomics?
20.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Oncoradiomics?
The register lists 7 active mandates at Oncoradiomics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Oncoradiomics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →